51³Ô¹ÏÍø

Spain Authorizes The First Trials On Phase 3 Of Johnson and Johnson's Vaccine Against Covid-19

MADRID, SPAIN – NOVEMBER 19: A sign for Johnson & Johnson is seen outside the Johnson & Johnson headquarters on November 19, 2020 in Madrid, Spain. The Spanish Agency for Medicines and Health Products (AEMPS) has authorized the first phase 3 clinical trial on November 18, 2020 for the COVID-19 vaccine from the company Janssen, belonging to the American multinational Johnson & Johnson. Trials of this vaccine had to be stopped due to "unexplained illness" in one participant. The tests were resumed eleven days later, after verifying that the event was not related to the administration of the drug. (Footage by David Benito/Getty Images)
MADRID, SPAIN – NOVEMBER 19: A sign for Johnson & Johnson is seen outside the Johnson & Johnson headquarters on November 19, 2020 in Madrid, Spain. The Spanish Agency for Medicines and Health Products (AEMPS) has authorized the first phase 3 clinical trial on November 18, 2020 for the COVID-19 vaccine from the company Janssen, belonging to the American multinational Johnson & Johnson. Trials of this vaccine had to be stopped due to "unexplained illness" in one participant. The tests were resumed eleven days later, after verifying that the event was not related to the administration of the drug. (Footage by David Benito/Getty Images)
PURCHASE A LICENSE

Get personalized pricing by telling us when, where, and how you want to use this asset.

DETAILS

Credit:
David Benito
Editorial #:
1286552112
Collection:
Getty Images News Video
Date created:
November 19, 2020
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:00:15:01
Location:
Madrid, Madrid, Spain
Mastered to:
MPEG-4 8-bit H.264 4K 3840x2160 50p
Originally shot on:
QuickTime - H.264 2160 50p
Source:
Getty Images News Video
Object name:
p1367019